February 15, 2019 article Open access Ebola virus disease The Lancet DOI: 10.1016/s0140-6736(18)33132-5 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 15 stored of 423 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Computational mining of B cell receptor repertoires reveals antigen-specific and convergent responses to Ebola vaccination 2024 Frontiers in Immunology article Medicine Viral Infections and Outbreaks Research Open access 5 citations Safety and Immunogenicity of an Accelerated Ebola Vaccination Schedule in People with and without Human Immunodeficiency Virus: A Randomized Clinical Trial 2024 Vaccines article Medicine Viral Infections and Outbreaks Research Open access 5 citations Helminth exposure and immune response to the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen 2024 PLoS neglected tropical diseases article Medicine Viral Infections and Outbreaks Research Open access 6 citations Lot-to-lot consistency, immunogenicity, and safety of the Ad26.ZEBOV, MVA-BN-Filo Ebola virus vaccine regimen: A phase 3, randomized, double-blind, placebo-controlled trial 2024 Human Vaccines & Immunotherapeutics article Medicine Viral Infections and Outbreaks Research Open access cited by 2 patents 8 citations Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study 2024 Vaccines article Medicine Viral Infections and Outbreaks Research Open access 7 citations Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone 2023 The Lancet Global Health article Medicine Viral Infections and Outbreaks Research Open access 18 citations Helminth exposure and immune response to the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen 2023 medRxiv preprint Medicine Viral Infections and Outbreaks Research Open access 1 citations Ebola virus–like particles reprogram cellular metabolism 2023 Journal of Molecular Medicine article Medicine Viral Infections and Outbreaks Research Open access 10 citations Targeted preventive vaccination campaigns to reduce Ebola outbreaks: An individual-based modeling study 2022 Vaccine article Medicine Viral Infections and Outbreaks Research 12 citations Model-based evaluation of the impact of prophylactic vaccination applied to Ebola epidemics in Sierra Leone and Democratic Republic of Congo 2022 BMC Infectious Diseases article Medicine Viral Infections and Outbreaks Research Open access 9 citations Monitoring of Adverse Events in Recipients of the 2-Dose Ebola Vaccine Regimen of Ad26.ZEBOV Followed by MVA-BN-Filo in the UMURINZI Ebola Vaccination Campaign 2022 The Journal of Infectious Diseases article Medicine Viral Infections and Outbreaks Research Open access 27 citations Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa 2021 PLoS Medicine article Medicine Viral Infections and Outbreaks Research Open access cited by 1 patent 69 citations Safety and Immunogenicity of an Accelerated Ebola Vaccination Schedule in People With and Without Human Immunodeficiency Virus: A Randomized Clinical Trial 2021 SSRN Electronic Journal preprint Medicine Viral Infections and Outbreaks Research Open access 0 citations Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial 2020 The Lancet Infectious Diseases article Medicine Viral Infections and Outbreaks Research Open access cited by 7 patents 173 citations Safety and Immunogenicity of Heterologous and Homologous 2-Dose Regimens of Adenovirus Serotype 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines: A Randomized, Controlled Phase 1 Study 2020 The Journal of Infectious Diseases article Medicine Viral Infections and Outbreaks Research Open access 41 citations 15 results References 0